SEPHS2 and Alzheimer disease: A meta-analysis of seven proteomics datasets focusing on brain tissues of AD patients revealed that both SEPHS2 and CLVS2 were downregulated (P = 6.92E−02 and P = 8.75E−03, respectively; Table S11) [20].